相似文献
1
Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2010 Aug;54(8):3516-9. doi: 10.1128/AAC.01756-09. Epub 2010 May 24.
2
Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.
Antimicrob Agents Chemother. 2005 Oct;49(10):4203-9. doi: 10.1128/AAC.49.10.4203-4209.2005.
3
Macrolide Resistance in .
Front Cell Infect Microbiol. 2016 Sep 21;6:98. doi: 10.3389/fcimb.2016.00098. eCollection 2016.
4
Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary.
Antimicrob Agents Chemother. 2005 May;49(5):1943-8. doi: 10.1128/AAC.49.5.1943-1948.2005.
5
Increase of macrolide-resistant Streptococcus pneumoniae-expressing mefE or ermB gene in the nasopharynx among children with otitis media.
Laryngoscope. 2005 Feb;115(2):317-20. doi: 10.1097/01.mlg.0000154740.48314.d5.
6
Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2011 Jul;55(7):3413-22. doi: 10.1128/AAC.00060-11. Epub 2011 May 2.
7
Phenotypic and genotypic characterization of Streptococcus pneumoniae resistant to macrolide in Casablanca, Morocco.
Infect Genet Evol. 2016 Jun;40:200-204. doi: 10.1016/j.meegid.2016.03.003. Epub 2016 Mar 4.
8
Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics.
J Antimicrob Chemother. 1999 May;43(5):637-43. doi: 10.1093/jac/43.5.637.
9
Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Antimicrob Agents Chemother. 2005 Feb;49(2):827-9. doi: 10.1128/AAC.49.2.827-829.2005.
10
Inducible Mega-Mediated Macrolide Resistance Confers Heteroresistance in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0131922. doi: 10.1128/aac.01319-22. Epub 2023 Feb 27.
引用本文的文献
1
Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.
Antibiotics (Basel). 2024 Dec 24;14(1):1. doi: 10.3390/antibiotics14010001.
2
Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.
Microorganisms. 2024 Jun 21;12(7):1259. doi: 10.3390/microorganisms12071259.
3
A Review of the Resistance Mechanisms for -Lactams, Macrolides and Fluoroquinolones among .
Medicina (Kaunas). 2023 Oct 31;59(11):1927. doi: 10.3390/medicina59111927.
4
Inducible Mega-Mediated Macrolide Resistance Confers Heteroresistance in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0131922. doi: 10.1128/aac.01319-22. Epub 2023 Feb 27.
5
Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health.
Sci Total Environ. 2023 Feb 20;860:160461. doi: 10.1016/j.scitotenv.2022.160461. Epub 2022 Nov 23.
6
Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.
Microorganisms. 2022 Jun 16;10(6):1239. doi: 10.3390/microorganisms10061239.
7
Multiple roles of ribosomal antimicrobial peptides in tackling global antimicrobial resistance.
R Soc Open Sci. 2022 Jan 26;9(1):211583. doi: 10.1098/rsos.211583. eCollection 2022 Jan.
8
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.
Antibiotics (Basel). 2021 May 29;10(6):650. doi: 10.3390/antibiotics10060650.
9
Comparative population genomic analyses of transporters within the Asgard archaeal superphylum.
PLoS One. 2021 Mar 26;16(3):e0247806. doi: 10.1371/journal.pone.0247806. eCollection 2021.
10
Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities.
Biophys Rev. 2021 Jan 21;13(1):35-69. doi: 10.1007/s12551-021-00784-y. eCollection 2021 Feb.
本文引用的文献
1
Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin.
Antimicrob Agents Chemother. 2010 Jan;54(1):440-51. doi: 10.1128/AAC.00769-09. Epub 2009 Nov 16.
2
Increase in pneumococcus macrolide resistance, United States.
Emerg Infect Dis. 2009 Aug;15(8):1260-4. doi: 10.3201/eid1508.081187.
3
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.
Trends Immunol. 2009 Mar;30(3):131-41. doi: 10.1016/j.it.2008.12.003. Epub 2009 Feb 13.
4
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16755-60. doi: 10.1073/pnas.0803815105. Epub 2008 Oct 20.
5
At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia.
Clin Infect Dis. 2008 Apr 15;46(8):1131-8. doi: 10.1086/529440.
6
A case series of macrolide treatment failures in community acquired pneumonia.
J Chemother. 2007 Oct;19(5):536-45. doi: 10.1179/joc.2007.19.5.536.
7
A new integrative reporter plasmid for Streptococcus pneumoniae.
FEMS Microbiol Lett. 2007 Mar;268(2):217-24. doi: 10.1111/j.1574-6968.2006.00584.x.
8
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
Clin Infect Dis. 2007 Mar 1;44 Suppl 2(Suppl 2):S27-72. doi: 10.1086/511159.
9
Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps.
Cell Microbiol. 2007 May;9(5):1162-71. doi: 10.1111/j.1462-5822.2006.00857.x. Epub 2007 Jan 9.
10
A functional dlt operon, encoding proteins required for incorporation of d-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae.
J Bacteriol. 2006 Aug;188(16):5797-805. doi: 10.1128/JB.00336-06.
Zotero 插件